Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
9.69
-0.19 (-1.92%)
At close: Jun 26, 2026, 4:00 PM EDT
9.88
+0.19 (1.96%)
After-hours: Jun 26, 2026, 7:40 PM EDT
AVR Employees
Anteris Technologies Global had 174 employees as of December 31, 2025. The number of employees increased by 38 or 27.94% compared to the previous year.
Employees
174
Change (1Y)
38
Growth (1Y)
27.94%
Revenue / Employee
$10,638
Profits / Employee
-$547,724
Market Cap
943.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 174 | 38 | 27.94% |
| Dec 31, 2024 | 136 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 14,000 |
| Azenta | 2,900 |
| AtriCure | 1,350 |
| STAAR Surgical Company | 921 |
| AngioDynamics | 675 |
| LeMaitre Vascular | 655 |
| Kestra Medical Technologies | 330 |
| Alamar Biosciences | 222 |
AVR News
- 20 days ago - Anteris Technologies cleared by ANSM for DurAVR THV trial - TheFly
- 20 days ago - Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - GlobeNewsWire
- 6 weeks ago - Anteris Technologies price target raised to $18 from $17 at Barclays - TheFly
- 6 weeks ago - Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Anteris Announces Results for the First Quarter of 2026 - GlobeNewsWire
- 7 weeks ago - Anteris Technologies: First U.S. patients treated in global PARADIGM trial - TheFly
- 7 weeks ago - Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial - GlobeNewsWire
- 2 months ago - Anteris Technologies secures CMS reimbursement for trial site activation - TheFly